{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:44:42Z","timestamp":1766159082421},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T00:00:00Z","timestamp":1677888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,4]]},"DOI":"10.1093\/neuonc\/noad049","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T12:33:13Z","timestamp":1677933193000},"page":"839-840","source":"Crossref","is-referenced-by-count":1,"title":["While paradigms shift in von Hippel-Lindau management, questions remain in optimal multidisciplinary neuro-oncology care"],"prefix":"10.1093","volume":"25","author":[{"given":"Roy E","family":"Strowd","sequence":"first","affiliation":[{"name":"Departments of Neurology, Internal Medicine, and the Translational Sciences Institute, Comprehensive Cancer Center, Wake Forest School of Medicine , 1 Medical Center Boulevard, Winston Salem, NC 27157"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,3,4]]},"reference":[{"issue":"22","key":"2023050411213023400_CIT0001","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-22-1054","article-title":"FDA approval summary: belzutifan for von Hippel-Lindau disease-associated tumors","volume":"28","author":"Fallah","year":"2022","journal-title":"Clin Cancer Res."},{"issue":"22","key":"2023050411213023400_CIT0002","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med."},{"issue":"1","key":"2023050411213023400_CIT0003","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01994821","article-title":"\u00dcber eine sehr seltene Erkrankung der Netzhaut\u2014Klinische Beobachtungen.","volume":"59","author":"v. Hippel","year":"1904","journal-title":"Albr von Gr\u00e6fe\u2019s Arch f\u00fcr Ophthalmol."},{"issue":"1\u20132","key":"2023050411213023400_CIT0004","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1755-3768.1926.tb07786.x","article-title":"Zur frage der angiomatosis retin\u00e6 und ihrer hirnkomplikationen","volume":"4","author":"Lindau","year":"1926","journal-title":"Acta Ophthalmol."},{"issue":"4","key":"2023050411213023400_CIT0005","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3171\/2015.1.JNS131963","article-title":"Arvid Lindau and discovery of von Hippel-Lindau disease","volume":"123","author":"Huntoon","year":"2015","journal-title":"J Neurosurg."},{"issue":"5112","key":"2023050411213023400_CIT0006","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene","volume":"260","author":"Latif","year":"1993","journal-title":"Science (80\u2212)."},{"key":"2023050411213023400_CIT0007","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80774","article-title":"Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata","volume":"11","author":"Ohh","year":"2022","journal-title":"Elife."},{"issue":"10","key":"2023050411213023400_CIT0008","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/gim.2017.261","article-title":"Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-\u03b1 binding site in VHL protein","volume":"20","author":"Liu","year":"2018","journal-title":"Genet Med."},{"issue":"5","key":"2023050411213023400_CIT0009","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/13543784.2021.1925248","article-title":"MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma","volume":"30","author":"Hasanov","year":"2021","journal-title":"Expert Opin Investig Drugs."},{"issue":"5","key":"2023050411213023400_CIT0010","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/neuonc\/noac234","article-title":"Neurological applications of belzutifan in von Hippel Lindau disease","volume":"25","author":"Zhang","year":"2023","journal-title":"Neuro Oncol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noad049\/49538065\/noad049.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/5\/839\/50196245\/noad049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/5\/839\/50196245\/noad049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T07:55:18Z","timestamp":1702022118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/25\/5\/839\/7069356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,3,4]]},"published-print":{"date-parts":[[2023,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad049","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2023,3,4]]}}}